Cluster Health Capital

Germany's Capital Region Berlin-Brandenburg - Your Partner for Next Generation in vitro-Diagnostics

In vitro-Diagnostics and Bioanalysis in Berlin-Brandenburg means:

  • about 20 research institutes focus on the identification of new biomarkers and new platform technologies for diagnostic tools
  • about 100 small and medium enterprises (SME) as manufacturer or supplier cover a broad spectrum of highly innovative diagnostics for the use in fundamental and applied research, the clinical routine laboratory and in Point-of-Care testing systems
  • Berlin-Brandenburg develops solutions to next generation in vitro-Diagnostics and Bioanalysis like sensor-actor-molecules and autonomous biosensors, genome-, proteome- and glycan-based multiplex analytics (microarray- and bead technologies) and metabolomics platforms for new biomarker strategies
  • Customers form research and industry may have access to upscaling biochip and biosensor production technologies and advanced biobanking infrastructures
  • Berlin-Brandenburg is the place for implementing clinical validation studies. Germany's most diversified hospital landscape with the Charité - Universitätsmedizin Berlin has access to pationt cohorts of urban and rural populations of about 180 ethnicities, covering all medical indications

We are the platform for Technology Transfer and support cooperations between science, clinics and industry. As part of Health Capital we are your interface to get access to Berlin-Brandenburg's expertise in in vitro-Diagnostics and Bioanalytics.